Femasys (FEMY) Cash & Equivalents (2020 - 2026)

Femasys has reported Cash & Equivalents for 7 years, with the latest figure at $5.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 40.99% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 40.99% YoY), and the FY2025 full-year result was $9.3 million, up 168.45% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $5.4 million, down from $9.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $21.8 million in Q1 2022, with the low at $3.2 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $11.2 million across 5 years, with a median of $10.2 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Equivalents sank 84.11% — and 2025, when it surged 168.45%.
• Femasys' Cash & Equivalents stood at $13.0 million in 2022, then soared by 67.54% to $21.7 million in 2023, then slumped by 84.11% to $3.5 million in 2024, then surged by 168.45% to $9.3 million in 2025, then slumped by 41.88% to $5.4 million in 2026.
• The last three Cash & Equivalents figures came in at $5.4 million (Q1 2026), $9.3 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.